Marpai, Inc. (MRAI)
| Previous close | 0.7700 |
| Open | 0.7700 |
| Bid | 0.7200 x 0 |
| Ask | 0.7999 x 0 |
| Day's range | 0.7000 - 0.7700 |
| 52-week range | 0.3300 - 3.4600 |
| Volume | |
| Avg. volume | 135,927 |
| Market cap | 7.941M |
| Beta (5Y monthly) | 4.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.9200 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.00 |
GlobeNewswireOTC Markets Group Welcomes Marpai, Inc. to OTCQX
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Marpai, Inc. (OTCQX: MRAI), an independent national Third-Party Administration (TPA) company, has qualified to trade on the OTCQX® Best Market. Marpai, Inc. previously traded on NASDAQ. Marpai, Inc. begins trading today on OTCQX under the symbol “MRAI.” U.S. investors can find current financial disclosure and Real-Tim
PR NewswireMARPAI ANNOUNCES WITHDRAWAL FROM NASDAQ HEARINGS PROCESS AND WILL TRANSITION TRADING TO THE OTCQX MARKET
Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced it has informed The Nasdaq Stock Market LLC of its intention to withdraw from the Nasdaq hearings process and transition the listing of its Class A common shares, par value $0.0001 per share (the "Shares"), from The Nasdaq Capital Mark
- GuruFocus.com
Marpai Inc (MRAI) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and Financial ...
Despite revenue declines, Marpai Inc (MRAI) reports significant improvements in operational efficiency and financial stability in Q1 2024.
